Fundies.
English

Regen BioPharma Inc

EDGAR
RGBP Quarterly report (10-Q) · filed 2026-08-17

Annual consolidated revenue for 2025: about USD 236.6K, using the latest reported figures. The previous period, 2024, was about USD 236.6K.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

59.1 thousand USD

2026 Q3 · USD

Exact inputs and evidence

Operating margin

41.53%

2026 Q3 · %

Exact inputs and evidence

Operating cash flow

-24.1 thousand USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -285244 USD Source
  • Operating Cash Flow: -261175 USD Source
Cash and cash equivalents
239 USD Source
Exact value

239 USD

Long-term debt including current maturities
Not available
Shares outstanding
1.13 billion shares Source
Exact value

1129988004 shares

Reported share-count change

3,481.04% · 1.1 billion shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 31554704 shares · 2025-06-30· Source
  • 1129988004 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

237 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Revenue: 236561 USD · 2024-10-01 – 2025-09-30 Source
  • Revenue: 177195 USD · 2024-10-01 – 2025-06-30 Source
  • Revenue: 59065 USD · 2025-10-01 – 2025-12-31 Source
  • Revenue: 59065 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 59065 USD · 2026-04-01 – 2026-06-30 Source

Net income

-1.19 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -1274502 USD · 2024-10-01 – 2025-09-30 Source
  • Net income: -702033 USD · 2024-10-01 – 2025-06-30 Source
  • Net income: -967853 USD · 2025-10-01 – 2025-12-31 Source
  • Net income: 991927 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -637785 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-445 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -383591 USD · 2024-10-01 – 2025-09-30 Source
  • Operating cash flow: -223586 USD · 2024-10-01 – 2025-06-30 Source
  • Operating cash flow: -197941 USD · 2025-10-01 – 2025-12-31 Source
  • Operating cash flow: -261175 USD · 2025-10-01 – 2026-03-31 Source
  • Operating cash flow: -197941 USD · 2025-10-01 – 2025-12-31 Source
  • Operating cash flow: -285244 USD · 2025-10-01 – 2026-06-30 Source
  • Operating cash flow: -261175 USD · 2025-10-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-17.

Financial data available through: 2025-09-30.

Coverage by financial measure
  • Revenue: 11 of 11 periods available· newest 2025-09-30
  • Operating income: 11 of 11 periods available· newest 2025-09-30
  • Net income: 11 of 11 periods available· newest 2025-09-30
  • Operating cash flow: 11 of 11 periods available· newest 2025-09-30
  • capital expenditure: No compatible figures in this window
  • Total assets: 11 of 11 periods available· newest 2025-09-30
  • Total liabilities: 11 of 11 periods available· newest 2025-09-30
  • Current assets: 11 of 11 periods available· newest 2025-09-30
  • Current liabilities: 11 of 11 periods available· newest 2025-09-30
  • Cash and cash equivalents: 11 of 11 periods available· newest 2025-09-30
  • long term debt: No compatible figures in this window
  • Shares outstanding: 11 of 11 periods available· newest 2025-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    0%

    Prior period

    USD 236,560

    –

    Current period

    USD 236,561

    –

    Exact inputs and evidence

    236561 − 236560 = 1 USD

    236560 USD · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    236561 USD · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −USD 606,247

    Prior period

    −USD 668,255

    –

    Current period

    −USD 1.27 million

    –

    Exact inputs and evidence

    -1274502 − -668255 = -606247 USD

    -668255 USD · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    -1274502 USD · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 367,945

    Prior period

    −USD 751,536

    –

    Current period

    −USD 383,591

    –

    Exact inputs and evidence

    -383591 − -751536 = 367945 USD

    -751536 USD · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    -383591 USD · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2024-10-01 – 2025-09-30

  • Revenue USD 236,561 100% of revenue
  • Operating costs Derived USD 575,101 243% of revenue
  • Operating income −USD 338,540 −143% of revenue
  • Tax, interest and other Derived USD 935,962 396% of revenue
  • Net income −USD 1.27 million −539% of revenue

Cash

  • Operating cash flow −USD 383,591 −162% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2016 Operating loss: operating costs were 3,057% of revenue.
  • 2017 Operating loss: operating costs were 2,383% of revenue.
  • 2018 Operating loss: operating costs were 1,526% of revenue.
  • 2019 Operating loss: operating costs were 788% of revenue.
  • 2020 Operating loss: operating costs were 290% of revenue.
  • 2021 Operating loss: operating costs were 428% of revenue.
  • 2022 Operating loss: operating costs were 371% of revenue.
  • 2023 Operating loss: operating costs were 390% of revenue.
  • 2024 Operating loss: operating costs were 276% of revenue.
  • 2025 Operating loss: operating costs were 243% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2016 2015-10-01 – 2016-09-30100000 3056962 Derived -2956962 4793632 Derived -7750594 Unavailable
Source
2017 2016-10-01 – 2017-09-30110000 2620885 Derived -2510885 3328153 Derived -5839038 Unavailable
Source
2018 2017-10-01 – 2018-09-30100000 1525783 Derived -1425783 3289417 Derived -4715200 Unavailable
Source
2019 2018-10-01 – 2019-09-30110000 866785 Derived -756785 1866391 Derived -2623176 Unavailable
Source
2020 2019-10-01 – 2020-09-30110000 319317 Derived -209317 -3623736 Derived 3414419 Unavailable
Source
2021 2020-10-01 – 2021-09-3061194 261965 Derived -200771 6564462 Derived -6765233 Unavailable
Source
2022 2021-10-01 – 2022-09-30125517 465122 Derived -339605 -2783136 Derived 2443531 Unavailable
Source
2023 2022-10-01 – 2023-09-30236560 923510 Derived -686950 -1843457 Derived 1156507 Unavailable
Source
2024 2023-10-01 – 2024-09-30236560 653781 Derived -417221 251034 Derived -668255 Unavailable
Source
2025 2024-10-01 – 2025-09-30236561 575101 Derived -338540 935962 Derived -1274502 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 236.6K 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.255.5K191.6K127.7K63.9K0.0201620212025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Revenue100000
2017Revenue110000
2018Revenue100000
2019Revenue110000
2020Revenue110000
2021Revenue61194
2022Revenue125517
2023Revenue236560
2024Revenue236560
2025Revenue236561

Revenue growth

Change in revenue from the same financial period one year earlier.

0% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.117%73%29%-16%-60%201620212025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2016Year over year-47.9%
2017Year over year10%
2018Year over year-9.1%
2019Year over year10%
2020Year over year0%
2021Year over year-44.4%
2022Year over year105.1%
2023Year over year88.5%
2024Year over year0%
2025Year over year0%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -143.1% 2025
Net margin -538.8% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4,237%131%-3,976%-8,082%-12,188%201620212025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2016Operating margin-2,957%
2017Operating margin-2,282.6%
2018Operating margin-1,425.8%
2019Operating margin-688%
2020Operating margin-190.3%
2021Operating margin-328.1%
2022Operating margin-270.6%
2023Operating margin-290.4%
2024Operating margin-176.4%
2025Operating margin-143.1%
2016Net margin-7,750.6%
2017Net margin-5,308.2%
2018Net margin-4,715.2%
2019Net margin-2,384.7%
2020Net margin3,104%
2021Net margin-11,055.4%
2022Net margin1,946.8%
2023Net margin488.9%
2024Net margin-282.5%
2025Net margin-538.8%
2016Free cash flow marginNot reported
2017Free cash flow marginNot reported
2018Free cash flow marginNot reported
2019Free cash flow marginNot reported
2020Free cash flow marginNot reported
2021Free cash flow marginNot reported
2022Free cash flow marginNot reported
2023Free cash flow marginNot reported
2024Free cash flow marginNot reported
2025Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -383.6K 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.171.7K-383.1K-937.9K-1.5M-2.0M201620212025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Operating cash flow-1672245
2017Operating cash flow-1894419
2018Operating cash flow-1577836
2019Operating cash flow-481792
2020Operating cash flow18645
2021Operating cash flow-1130938
2022Operating cash flow-606921
2023Operating cash flow-173917
2024Operating cash flow-751536
2025Operating cash flow-383591

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Free cash flowUnavailable
2017Free cash flowUnavailable
2018Free cash flowUnavailable
2019Free cash flowUnavailable
2020Free cash flowUnavailable
2021Free cash flowUnavailable
2022Free cash flowUnavailable
2023Free cash flowUnavailable
2024Free cash flowUnavailable
2025Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

2,387.2% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.11,998%8,999%5,999%3,000%0%201620212025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2016Liabilities / assets283.8%
2017Liabilities / assets656.1%
2018Liabilities / assets4,464.1%
2019Liabilities / assets11,109.3%
2020Liabilities / assets6,054.3%
2021Liabilities / assets1,212.6%
2022Liabilities / assets1,537.6%
2023Liabilities / assets1,543.4%
2024Liabilities / assets3,338.9%
2025Liabilities / assets2,387.2%

Current assets to current liabilities

Current assets divided by current liabilities.

0.04× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.28×0.21×0.14×0.07×0.00×201620212025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2016Current assets / current liabilities0.26×
2017Current assets / current liabilities0.08×
2018Current assets / current liabilities0×
2019Current assets / current liabilities0.01×
2020Current assets / current liabilities0.01×
2021Current assets / current liabilities0.07×
2022Current assets / current liabilities0.04×
2023Current assets / current liabilities0.02×
2024Current assets / current liabilities0.03×
2025Current assets / current liabilities0.04×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2015-10-01 – 2016-09-30
−USD 7.75 million
Exact value

Exact value: -7750594 USD

2015-10-01 – 2016-09-30: -7750594 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.67 million
Exact value

Exact value: -1672245 USD

2015-10-01 – 2016-09-30: -1672245 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2017 2016-10-01 – 2017-09-30
−USD 5.84 million
Exact value

Exact value: -5839038 USD

2016-10-01 – 2017-09-30: -5839038 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.89 million
Exact value

Exact value: -1894419 USD

2016-10-01 – 2017-09-30: -1894419 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2018 2017-10-01 – 2018-09-30
−USD 4.72 million
Exact value

Exact value: -4715200 USD

2017-10-01 – 2018-09-30: -4715200 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.58 million
Exact value

Exact value: -1577836 USD

2017-10-01 – 2018-09-30: -1577836 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2019 2018-10-01 – 2019-09-30
−USD 2.62 million
Exact value

Exact value: -2623176 USD

2018-10-01 – 2019-09-30: -2623176 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 481,792
Exact value

Exact value: -481792 USD

2018-10-01 – 2019-09-30: -481792 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2020 2019-10-01 – 2020-09-30
USD 3.41 million
Exact value

Exact value: 3414419 USD

2019-10-01 – 2020-09-30: 3414419 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 18,645
Exact value

Exact value: 18645 USD

2019-10-01 – 2020-09-30: 18645 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2020-10-01 – 2021-09-30
−USD 6.77 million
Exact value

Exact value: -6765233 USD

2020-10-01 – 2021-09-30: -6765233 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.13 million
Exact value

Exact value: -1130938 USD

2020-10-01 – 2021-09-30: -1130938 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2021-10-01 – 2022-09-30
USD 2.44 million
Exact value

Exact value: 2443531 USD

2021-10-01 – 2022-09-30: 2443531 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 606,921
Exact value

Exact value: -606921 USD

2021-10-01 – 2022-09-30: -606921 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2022-10-01 – 2023-09-30
USD 1.16 million
Exact value

Exact value: 1156507 USD

2022-10-01 – 2023-09-30: 1156507 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 173,917
Exact value

Exact value: -173917 USD

2022-10-01 – 2023-09-30: -173917 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2023-10-01 – 2024-09-30
−USD 668,255
Exact value

Exact value: -668255 USD

2023-10-01 – 2024-09-30: -668255 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 751,536
Exact value

Exact value: -751536 USD

2023-10-01 – 2024-09-30: -751536 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2024-10-01 – 2025-09-30
−USD 1.27 million
Exact value

Exact value: -1274502 USD

2024-10-01 – 2025-09-30: -1274502 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 383,591
Exact value

Exact value: -383591 USD

2024-10-01 – 2025-09-30: -383591 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

73 filings · 2,792 latest values · 2,792 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001589150, 1589150, RGBP, RGBPP, edgar:1589150

Also known as REGEN BIOPHARMA INC, REGEN BIOPHARMA, INC, REGEN BIOPHARMA, INC., Regen BioPharma Inc